Open AccessShort Commentary on Approved Medications for COVID -19 Management?
Author(s) -
Jaidev Kumar,
Mahendrappa,
Shwetha,
Harshith
Publication year - 2021
Publication title -
journal of drug delivery and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2250-1177
DOI - 10.22270/jddt.v11i6-s.5112
Subject(s) - covid-19 , medicine , intensive care medicine , drug , population , pharmacology , virology , infectious disease (medical specialty) , disease , environmental health , outbreak
Every clinician who prescribes antiviral drug during COVID-19 should be very careful and needs to assess following factors such as hepatic and renal function status, specialized population such as Geriatric, Pediatric etc, co morbidities of patient, allergic history of drug, COVID-19 severity status, clinical evidence in management of COVID-19 and duration of drug therapy in COVID-19.